Theophylline/ephedra/hydroxyzine
Combination of | |
---|---|
Theophylline | Stimulant |
Ephedra | Stimulant |
Hydroxyzine | Antihistamine |
Clinical data | |
Trade names | Marax |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | By mouth |
ATC code | |
Identifiers | |
CAS Number |
|
PubChem SID |
Theophylline/ephedra/hydroxyzine (trade name Marax) is a drug that was used for the treatment of asthma. It was a combination of theophylline, ephedra,[1] and hydroxyzine, and taken by mouth.[2][3] It is no longer being manufactured in the US due to ephedra being removed from approval by the FDA.[citation needed]
References[]
- ^ Hunt TM (2011). Drug Games: The International Olympic Committee and the Politics of Doping, 1960–2008. University of Texas Press. p. 45. ISBN 978-0-292-73957-4. Retrieved 20 July 2018.
- ^ Marax Micromedex Detailed Consumer Information. Accessed 23 April 2021.
- ^ Fixley M, Shen DD, Azarnoff DL (June 1977). "Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline". The American Review of Respiratory Disease. 115 (6): 955–62. doi:10.1164/arrd.1977.115.6.955 (inactive 2021-05-06). PMID 262107.CS1 maint: DOI inactive as of May 2021 (link)
Categories:
- Bronchodilators
- Respiratory system drug stubs